Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | RAC-alpha serine/threonine-protein kinase | ||
Ligand | BDBM50528466 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1904982 (CHEMBL4407340) | ||
IC50 | 8.0±n/a nM | ||
Citation | Dong, X; Zhan, W; Zhao, M; Che, J; Dai, X; Wu, Y; Xu, L; Zhou, Y; Zhao, Y; Tian, T; Cheng, G; Jin, Z; Li, J; Shao, Y; He, Q; Yang, B; Weng, Q; Hu, Y Discovery of 3,4,6-Trisubstituted Piperidine Derivatives as Orally Active, Low hERG Blocking Akt Inhibitors via Conformational Restriction and Structure-Based Design. J Med Chem62:7264-7288 (2019) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
RAC-alpha serine/threonine-protein kinase | |||
Name: | RAC-alpha serine/threonine-protein kinase | ||
Synonyms: | AKT phosphorylation (p-AKT) | AKT1 | AKT1/PPP1CA | AKT1_HUMAN | C-AKT | PKB | PKB alpha | Protein kinase Akt-1 | Protein kinase B | Protein kinase B (AKT1) | Protein kinase B (Akt 1) | Protein kinase B (Akt) | Protein kinase B alpha | Protein kinase B alpha (AKT1) | Proto-oncogene Akt (Akt1) | Proto-oncogene c-Akt (AKT) | Proto-oncogene c-Akt (AKT1) | RAC | RAC-PK-alpha | RAC-alpha serine/threonine-protein kinase (AKT) | RAC-alpha serine/threonine-protein kinase (AKT1) | RAC-alpha serine/threonine-protein kinase (pAKT) | ||
Type: | Enzyme | ||
Mol. Mass.: | 55681.25 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P31749 | ||
Residue: | 480 | ||
Sequence: |
| ||
BDBM50528466 | |||
n/a | |||
Name | BDBM50528466 | ||
Synonyms: | CHEMBL4447158 | ||
Type | Small organic molecule | ||
Emp. Form. | C26H27Cl4N5O3 | ||
Mol. Mass. | 599.336 | ||
SMILES | Cn1ncc(Cl)c1-c1cc(oc1Cl)C(=O)N[C@@H]1CN[C@H](CC(=O)NC2CCC2)C[C@H]1c1ccc(Cl)c(Cl)c1 |r,wU:16.17,19.21,wD:29.33,(8.88,-41.02,;8.56,-42.52,;7.15,-43.15,;7.31,-44.68,;8.81,-45,;9.44,-46.41,;9.59,-43.67,;11.12,-43.51,;12.15,-44.66,;13.56,-44.04,;13.4,-42.5,;11.89,-42.18,;11.27,-40.77,;14.9,-44.81,;14.89,-46.35,;16.23,-44.04,;17.56,-44.82,;17.56,-46.35,;18.89,-47.13,;20.23,-46.36,;21.56,-47.13,;22.89,-46.37,;22.9,-44.83,;24.22,-47.14,;25.56,-46.38,;27.05,-46.79,;27.45,-45.3,;25.96,-44.9,;20.23,-44.81,;18.9,-44.05,;18.9,-42.52,;17.57,-41.75,;17.57,-40.2,;18.9,-39.43,;18.89,-37.89,;20.23,-40.2,;21.56,-39.42,;20.24,-41.75,)| | ||
Structure |